Moderna, Inc. · NASDAQ:MRNA
Klinger Shannon Thyme sold 3,471 Moderna, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Klinger Shannon Thyme (Chief Legal Officer) sold 3,471 Moderna, Inc. shares at US$139.95 for US$486K under a trading plan, leaving 75,247 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 3,471 shares
- Price
- US$139.95
- Value
- US$486K
- Holding after
- 75,247 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 3,471 | US$30.96 | 77,600 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 3,471 | US$139.95 | 74,129 | Direct |
| Sep 1, 2026 | Common Stock | Option exercise | 2,166 | 76,295 | Direct | |
| Sep 1, 2026 | Common Stock | Shares withheld for tax | 1,048 | US$140.34 | 75,247 | Direct |
Source
Related
- Moderna, Inc.
- Klinger Shannon Thyme
- Moderna, Inc. shareholders
- Form 4 · Klinger Shannon Thyme · Sep 8, 2026
- Form 4 · Klinger Shannon Thyme · Aug 31, 2026
- Form 4 · Klinger Shannon Thyme · Jun 8, 2026
- Form 4 · Klinger Shannon Thyme · Jun 3, 2026
- Form 4 · Klinger Shannon Thyme · May 29, 2026
- Form 4 · Hoge Stephen · Oct 16, 2026
- Form 4 · Mock James M · Oct 7, 2026
- Form 4 · Hoge Stephen · Sep 16, 2026
- Form 4 · Mock James M · Sep 14, 2026
- Form 4 · Mock James M · Sep 8, 2026